Prognostic factors of colorectal cancer: Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 4, 1996, Pages 408-415

  Takahashi, T ^a,b   Kato, T ^a   Kodaira, S ^a   Koyama, Y ^a   Sakabe, T ^a   Tominaga, T ^a   Hamano, K ^a   Yasutomi, M ^a   Ogawa, N ^a  

^a Colorectal Cancer Chemother S ^*  (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

5 FU; Adjuvant chemotherapy; Colorectal cancer; MMC; Multivariate analysis; Prospective randomized controlled study

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PROGNOSIS; PROSPECTIVE STUDY;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 0030015426     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199608000-00019     Document Type: Article

References (19)

1. Japanese Research Society for Cancer of the Colon and Rectum. multi-institutional registry of large bowel cancer in Japan (Vol. 7 Cases treated in 1983). 1992: Tochigi, Japan
2. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
3. Japanese Research Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 1983;13:557-73.
4. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-32.
5. Kirklin JW, Dockerty MB, Waugh JM. The role of the peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet 1949;88:326-31.
6. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-52.
7. Moertel CG, O'Fallon JR, Go VLW. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 1986;58:603-10.
8. Russo A, Bazan V, Plaja S. Patterns of DNA-ploidy in operable colorectal carcinoma: a prospective study of 100 cases. J Surg Oncol 1991;48:4-10.
9. Chapuis PH, Dent OF, Fisher R. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
10. Jass JR. Prognostic factors in colorectal cancer. Curr Top Pathol 1990;81:295-322.
11. Halvorsen TB, Seim E. Tumour site: a prognostic factor in colorectal cancer? A multivariate analysis. Scand J Gastroenterol 1987;22:124-8.
12. UK Co-ordinating Committee on Cancer Research. Clinicopathological staging booklet. UKCCCR, London, 1989.
13. Fielding LP, Arsenault PA, Chapuis PH. Clinicopathological staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol 1991;6:325-44.
14. Higgins GA, Humphrey E, Juler GL. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 1976;38: 1461-7.
15. Panettiere FJ, Goodman PJ, Costanzi JJ. Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. J Clin Oncol 1988;6:947-54.
16. Wunderlich M, Schiessel R, Rainer H. Effect of adjuvant chemoor immunotherapy on the prognosis of colorectal cancer operated for cure. Br J Surg 1985;72(suppl):S107-10.
17. Hoover HC, Brandhorst JS, Peters LC. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 1993;11:390-9.
18. Moertel CG, Fleming TR, MacDonald JS. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
19. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.